These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15798703)

  • 1. [Chronic heart failure in patients with type-2 diabetes].
    Strongin LG; Pochinka IG
    Kardiologiia; 2005; 45(2):33-6. PubMed ID: 15798703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between natriuretic peptides and echocardiography parameters in patients with poorly regulated type 2 diabetes.
    Dencker M; Stagmo M; Dorkhan M
    Vasc Health Risk Manag; 2010 Jun; 6():373-82. PubMed ID: 20539839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction.
    Pastormerlo LE; Mammini C; Giannoni A; Valleggi A; Prontera C; Gabutti A; Poletti R; Padeletti L; Emdin M; Passino C
    J Cardiovasc Med (Hagerstown); 2015 Jun; 16(6):423-30. PubMed ID: 25083720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemoglobin A1c predicts heart failure hospitalization independent of baseline cardiac function or B-type natriuretic peptide level.
    Kishimoto I; Makino H; Ohata Y; Tamanaha T; Tochiya M; Kada A; Ishihara M; Anzai T; Shimizu W; Yasuda S; Ogawa H
    Diabetes Res Clin Pract; 2014 May; 104(2):257-65. PubMed ID: 24629410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of ST2 and B-type natriuretic peptide in diabetic patients with acute heart failure: relation with ventricular stiffness and outcome.
    Ruocco G; Evangelista I; Franci B; Lucani B; Martini S; Nuti R; Palazzuoli A
    J Cardiovasc Med (Hagerstown); 2019 Feb; 20(2):81-90. PubMed ID: 30540645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of strict glycemic control on clinical state and course of the disease in patients with chronic heart failure and type II diabetes mellitus. Results of the REMBO "rational effective multicomponent therapy in the struggle against diabetes mellitus in patients with congestive heart failure" study].
    Lapina IuV; Filatov DN; Mareev VIu; Narusov OIu; Bolotina MG; Shestakova MV; Masenko VP; Litonova GN; Baklanova NA; Belenkov IuN
    Kardiologiia; 2008; 48(9):17-27. PubMed ID: 18991816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy and safety of the use of metformin in patients with chronic heart failure and type 2 diabetes mellitus. results of the study "rational effective mulicomponent therapy in the battle against diabetes mellitus in patients with chronic heart failure"].
    Lapina IuV; Narusov OIu; Mareev VIu; Bolotina MG; Shestakova MV; Masenko VP; Litonova GN; Arzamastseva NE; Baklanova NA; Belenkov IuN
    Kardiologiia; 2008; 48(3):58-68. PubMed ID: 18429758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between activity of atrial natriuretic peptide and process of myocardial remodelling in patients with cardiac failure].
    Fushteĭ IM; Berezin AE
    Klin Med (Mosk); 1998; 76(1):11-4. PubMed ID: 9532906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycemic control predicts diabetic extrarenal microvascular complications but not renal survival in patients with moderate to severe chronic kidney disease.
    Crook ED; Patel S
    Ethn Dis; 2006; 16(4):865-71. PubMed ID: 17061739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The plasma levels of atrial natriuretic peptide and brain natriuretic peptide in type 2 diabetes treated with sodium-glucose cotransporter-2 inhibitor.
    Feng X; Gu Q; Gao G; Yuan L; Li Q; Zhang Y
    Ann Endocrinol (Paris); 2020 Oct; 81(5):476-481. PubMed ID: 32822653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic phenotype and prognosis of patients with heart failure and preserved ejection fraction in a real life cohort.
    Lejeune S; Roy C; Slimani A; Pasquet A; Vancraeynest D; Vanoverschelde JL; Gerber BL; Beauloye C; Pouleur AC
    Cardiovasc Diabetol; 2021 Feb; 20(1):48. PubMed ID: 33608002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of arginine vasopressin with low atrial natriuretic peptide levels, left ventricular remodelling, and outcomes in adults with and without heart failure.
    Chirinos JA; Sardana M; Oldland G; Ansari B; Lee J; Hussain A; Mustafa A; Akers SR; Wei W; Lakatta EG; Fedorova OV
    ESC Heart Fail; 2018 Oct; 5(5):911-919. PubMed ID: 29969536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes.
    Boonman-de Winter LJ; Rutten FH; Cramer MJ; Landman MJ; Liem AH; Rutten GE; Hoes AW
    Diabetologia; 2012 Aug; 55(8):2154-62. PubMed ID: 22618812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of heart failure and the diagnostic value of MR-proANP in outpatients with type 2 diabetes.
    Jensen J; Schou M; Kistorp C; Faber J; Hansen TW; Jensen MT; Andersen HU; Rossing P; Vilsbøll T; Jørgensen PG
    Diabetes Obes Metab; 2019 Mar; 21(3):736-740. PubMed ID: 30447033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Type 2 Diabetes and All-Cause Hospitalization and Mortality in the UK General Heart Failure Population: Stratification by Diabetic Glycemic Control and Medication Intensification.
    Lawson CA; Jones PW; Teece L; Dunbar SB; Seferovic PM; Khunti K; Mamas M; Kadam UT
    JACC Heart Fail; 2018 Jan; 6(1):18-26. PubMed ID: 29032131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risks of diabetic nephropathy with variation in hemoglobin A1c and fasting plasma glucose.
    Lin CC; Chen CC; Chen FN; Li CI; Liu CS; Lin WY; Yang SY; Lee CC; Li TC
    Am J Med; 2013 Nov; 126(11):1017.e1-10. PubMed ID: 23993260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slightly elevated B-type natriuretic peptide levels in a non-heart failure range indicate a worse left ventricular diastolic function in individuals with, as compared with individuals without, type 2 diabetes: the Hoorn Study.
    van den Hurk K; Alssema M; Kamp O; Henry RM; Stehouwer CD; Diamant M; Boomsma F; Heine RJ; Nijpels G; Paulus WJ; Dekker JM
    Eur J Heart Fail; 2010 Sep; 12(9):958-65. PubMed ID: 20667891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between glycemic control and BNP levels in diabetic patients.
    Dal K; Ata N; Yavuz B; Sen O; Deveci OS; Aksoz Z; Yildirim AM; Uygungelen B; Akin KO; Beyan E; Ertugrul DT
    Cardiol J; 2014; 21(3):252-6. PubMed ID: 23990181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes Mellitus, Microalbuminuria, and Subclinical Cardiac Disease: Identification and Monitoring of Individuals at Risk of Heart Failure.
    Swoboda PP; McDiarmid AK; Erhayiem B; Ripley DP; Dobson LE; Garg P; Musa TA; Witte KK; Kearney MT; Barth JH; Ajjan R; Greenwood JP; Plein S
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28716801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raised natriuretic peptides, big-endothelin-1 and improved beta-cell function in type 2 diabetic males with hyperuricaemia.
    Hermans MP; Ahn SA; Rousseau MF
    Diab Vasc Dis Res; 2009 Jul; 6(3):190-3. PubMed ID: 20368210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.